NT5E and neoplasm: However, when anti-CD73 mAb or anti-PD-1 mAb or the combination of antibodies was administered 3 days following the last intrathecal (i.t.)reovirus treatment, combining treatments (reovirus plus antibody) significantly prolonged the tumor control of the mice beyond that observed with reovirus alone.